Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon

Virology Journal

Volumn 7, Issue , 2010, Pages

  Mahfoud, Ziyad ^a   Kassak, Kassem ^a   Kreidieh, Khalil ^a   Shamra, Sarah ^a   Ramia, Sami ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LEBANON; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PREVALENCE; QUALITATIVE ANALYSIS; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; WESTERN EUROPE; BLOOD; CLASSIFICATION; GENETICS; HEPATITIS C; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

HEPATITIS C ANTIBODY;

ADULT; DRUG USERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LEBANON; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77952032782     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-96     Document Type: Article

References (22)

1. Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population. Lucidarme D, Decoster A, Fremaux D, Harbonnier J, Jacob C, Vosgien V, Josse P, Villeger P, Henrio C, Prouvost-Keller B, Saccardy C, Lemaire M, Vazeille G, Duchene C, Thuillier M, Colbeaux C, Lefebvre AM, Forzy G, Filoche B, Gastroenterology and Clinical Biology 2007 31 480 484 10.1016/S0399-8320(07)89415-2 (Pubitemid 46877546)
2. Distribution of hepatitis C virus genotypes among injecting drug users in contract with treatment centers in Belgium 2004-2005. Micalessi M, Gerard C, Ameye L, Plasschaert S, Brochier B, Vranckx R, Journal of Medical Virology 2008 80 640 645 10.1002/jmv.21145 18297717 (Pubitemid 351358562)
3. The hepatitis C virus epidemic among injecting drug users, Infection. Pybus O, Cochrane A, Holmes E, Simmonds P, Genetics and Evolution 2005 5 131 139 10.1016/j.meegid.2004.08.001 (Pubitemid 40090232)
4. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R, Journal of Infection 2000 40 176 183 10.1053/jinf.2000.0647 10841096 (Pubitemid 30312558)
5. Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle exchange. Goldberg D, Burns S, Taylor A, Cameron S, Hargreavas D, Hutchison S, Scandinavian Journal Infectious Diseases 2001 33 457 461 10.1080/00365540152029936 (Pubitemid 32611425)
6. Classification of hepatitis C virus variants in six major types based on analysis of the envelop 1 and non-structural 5B genome regions and complete polyprotein sequences. de Lamballerie X, Charrel RN, Attoui H, De Miccop, Journal of General Virology 1997 78 45 51 9010284 (Pubitemid 27067511)
7. Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. Tokita H, Okamoto H, Luengrojanakul P, Vareesangthip K, Chainuvati T, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M, Journal of General Virology 1995 76 2329 2335 10.1099/0022-1317-76-9-2329 7561773
8. Hepatitis C virus variants from Jakarta, Indonesia, classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. Tokita H, Okamoto H, Iizuka H, Kishimoto J, Tsuda F, Lesmana LA, Miyakawa Y, Mayumi M, Journal of General Virology 1996 77 293 301 10.1099/0022-1317-77-2-293 8627233 (Pubitemid 26044148)
9. Variability of the hepatitis C genome. Simmonds P, Hepatitis C virus Karger, Basel, Reesink HW, 1998
10. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Sharara A, Ramia S, Ramlawi F, Eid-Fares J, Klayme S, Naman R, Epidemiology and Infection 2007 135 427 432 10.1017/S0950268806006911 16848924 (Pubitemid 46443428)
11. Hepatitis C virus molecular epidemiology in Uzbekistan. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M, Journal of Medical Virology 2003 69 367 375 10.1002/jmv.10298 12526047 (Pubitemid 36158317)
12. Viral hepatitis C. Poynard T, Yuen MF, Ratziu V, Lai CL, Lancet 2004 362 2095 2100 10.1016/S0140-6736(03)15109-4 (Pubitemid 38035201)
13. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D, Journal of Infectious Diseases 1995 171 1607 1610 7769300
14. Respondent-driven sampling: A new approach to the study of hidden populations. Heckathorn DD, Social Problems 1997 44 174 199 10.1525/sp.1997.44. 2.03x0221m
15. The use of the dried blood spot sample in epidemiological studies. Parker SP, Gubilt WD, J Clinical Pathology 1999 52 633 639 10.1136/jcp.52.9.633 (Pubitemid 29456898)
16. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotypes with clinical parameters with sex and drug- related risk behaviors. Mathei C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F, European Journal Clinical Microbiology and Infectious Diseases 2005 24 514 522 10.1007/s10096-005-1376-9 (Pubitemid 41414000)
17. Hepatitis C virus infection. Lauer GM, Walker BD, New England Journal of Medicine 2001 345 41 52 10.1056/NEJM200107053450107 11439948 (Pubitemid 32634271)
18. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Freeman AJ, Zekry A, Whybin LR, Harvey CE, van Beek IA, de Kantzow SL, Rawlinson WD, Boughton CR, Robertson PW, Marinos G, Lloyd AR, Medical Journal of Australia 2000 172 588 591 10914104 (Pubitemid 30438934)
19. Is the prevalence of hepatitis C virus (HCV) RNA in an anti-HCV-positive injection drug users positively correlated with age? Mathei C, Buntinx F, Van Damme P, Journal of Infectious Diseases 2001 184 659 660 10.1086/322795 11494175 (Pubitemid 32783563)
20. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli M, Journal of Hepatology 1995 22 691 695 10.1016/0168-8278(95)80225-8 7560863
21. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, Afshar P, Ono-Kihara M, Ravari SM, Kihara M, International Journal of Drug Policy 2007 18 359 563 10.1016/j.drugpo.2007.02.007 17854723 (Pubitemid 47374506)
22. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. Alzahrani AJ, Journal of Medical Virology 2008 80 603 606 10.1002/jmv.21075 18297713 (Pubitemid 351358556)